Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has started a strategic review that could see it leave AIM to cut costs and gain flexibility. The company says its shares remain undervalued, with low trading volumes in the UK small-cap market.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) second European patent for a SIRT6 variant in NASH has been published, granting provisional protection. This strengthens the company’s IP portfolio and supports its longevity and metabolic disease programs.
MedPal (AIM:MPAL) has opened a 24/7 national distribution centre in Swaffham using automation to process over 100,000 prescriptions a month. The new hub combines AI consultations with robotic dispensing for same-day or next-day medicine delivery.
Mosman Oil and Gas Ltd (AIM:MSMN) has raised £500,000 from a fully subscribed retail offer, taking its total equity raise to £2.17 million. The funds will support further work on its helium assets in Colorado, including seismic and well testing.
Oxford BioDynamics Plc (AIM:OBD) has raised £7 million through a placing and subscription at £0.003 per share. The proceeds will fund operations and growth as PSE Test sales rise and new partnerships advance.
European Green Transition PLC (AIM:EGT) has named entrepreneur Mick Kearney as an independent non-executive director. Kearney brings experience from business and sport, including roles with Snap Printing and the Irish national rugby team.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
